Azin Alizadehasl: Exploring SGLT2 Inhibitors as Cardioprotective Agents in Cardio-Oncology
Azin Alizadehasl/LinkedIn

Azin Alizadehasl: Exploring SGLT2 Inhibitors as Cardioprotective Agents in Cardio-Oncology

Azin Alizadehasl, Professor of Cardiology at Rajaie Cardiovascular, Medical and Research Institute, shared a post on Linkedin:

“Information collected regarding ‘SGLT2 inhibitors in Cardio-Oncology‘.

I hope it will be useful for fellows and colleagues.”

Echocardiography Channel

Azin Alizadehasl

Other articles featuring Azin Alizadehasl and cardiotoxicity on OncoDaily.